HeartFlow, Inc. (HTFL)
NASDAQ:HTFL
Want to see HTFL full AI Analyst Report?
HTFL Stock Chart & Stats
$31.34
--
Market closed
$31.34
--
Day’s Range― - ―
52-Week Range$20.13 - $41.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.16M
Market Cap
$2.55B
Enterprise Value$2.68B
Total Cash (Recent Filing)$158.32M
Total Debt (Recent Filing)$26.35M
Price to Earnings (P/E)―
Beta2.36
Next Earnings
Aug 06, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.04
Shares Outstanding86,240,830
10 Day Avg. Volume1,348,495
30 Day Avg. Volume1,158,136
Financial Highlights & Ratios
PEG Ratio1.16
Price to Book (P/B)35.73
Price to Sales (P/S)61.03
P/FCF Ratio-181.94
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue13.99
Enterprise Value/Gross Profit17.93
Enterprise Value/Ebitda-30.59
Forecast
1Y Price Target
$37.00Price Target Upside18.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)-0.49
Revenue Forecast (FY)$229.92M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained, accelerating revenue demonstrates strong clinical adoption of the HeartFlow FFRCT service and effective commercial execution. A growing per-study revenue base supports scale, increases addressable-market penetration, and creates a foundation for operating leverage as fixed costs are absorbed over larger volumes.
High/Improving Gross MarginsElevated and rising gross margins indicate attractive unit economics for the software-based diagnostic service. High contribution margins support sustainable profitability once operating expenses moderate, enabling scalable growth and reinvestment in sales, product development, and market expansion.
Lower Leverage / Healthier 2025 Balance SheetMaterial debt reduction and a low debt-to-equity ratio materially lower solvency risk and refinancing pressure. A healthier 2025 capital structure gives the company runway to invest in commercialization and product development while reducing short-term liquidity risk compared with prior years.
Bears Say
Persistent Net LossesLarge ongoing operating and net losses mean the business has not yet converted top-line traction into profitability. Continued negative margins constrain ability to self-fund growth, prolong dependence on external capital, and heighten execution risk before a durable profit inflection is achieved.
Negative Operating & Free Cash FlowConsistent negative operating and free cash flow indicate ongoing cash burn despite improvement. This structural cash deficit forces reliance on financing, which can dilute shareholders or restrict strategic options, and raises short-to-medium term risk if margins or growth slow.
Volatile Capital Structure / Past Negative EquityA history of negative equity signals prior accumulated losses or recapitalizations, reflecting volatility in financial health. Such capital-structure instability can reduce partner and lender confidence, complicate forecasting, and increase the probability of future dilutive financing events.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $20.13 and its highest was $41.22 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
HeartFlow, Inc.’s market cap is $2.55B.
When is HeartFlow, Inc.’s upcoming earnings report date?
HeartFlow, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 64 days.
How were HeartFlow, Inc.’s earnings last quarter?
HeartFlow, Inc. released its earnings results on May 14, 2026. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.188 by $0.028.
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate is -0.13.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 86,240,830 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
HeartFlow, Inc. reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.188. Following the earnings report the stock price went down -12.174%.
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HeartFlow, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.00 (18.06% Upside)
$37.00 (18.06% Upside)
Blogger Sentiment
Bullish
HTFL Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $58.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
830.46%
Trailing 12-Months
Asset Growth
86.52%
Trailing 12-Months
Company Description
HeartFlow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Earnings Call
Q1 2026
0:00 / 0:00
HTFL Stock 12 Month Forecast
Average Price Target
$37.00
▲(18.06% Upside)
Technical Analysis
Ownership Overview
17.80% Insiders
21.90% Mutual Funds
28.76% Other Institutional Investors
25.68% Public Companies and
Individual Investors